References
- Basit H, Alahmadi MH, Rout P, Sharma S. Hypertrophic cardiomyopathy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jun 7. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK430788/ - Maron MS. Hypertrophic cardiomyopathy: Clinical manifestations, diagnosis, and evaluation. J Am Coll Cardiol. 2022 Feb 1;79(4):372–389. doi: 10.1016/j.jacc.2021.12.002
- Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. Circulation. 2020 Dec 22;142(25):e558–e631. doi: 10.1161/CIR.0000000000000937
- Marian AJ, Braunwald E. Hypertrophic cardiomyopathy: Genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017 Jul 7;121(7):749–770. doi: 10.1161/CIRCRESAHA.116.309348
- Shah SN. Hypertrophic cardiomyopathy medication. Medscape. 2024 Aug 14. Available from:
https://emedicine.medscape.com/article/152913-overview - Cassagnol M, Ball P, Bhimji SS. Managing hypertrophic cardiomyopathy. US Pharm. 2016;41(5):HS8–HS12.
- Hidalgo LF, Sanz-Sánchez N, Sánchez A. Pharmacological and non-pharmacological treatment of obstructive hypertrophic cardiomyopathy. Expert Rev Cardiovasc Ther. 2017;16(1):21–26. doi: 10.1080/14779072.2018.1417038
- Coylewright M, Masri A, Martinez MW. 2024 hypertrophic cardiomyopathy guideline-at-a-glance. J Am Coll Cardiol. 2024 Jun;83(23):2406–2410. doi: 10.1016/j.jacc.2024.04.012
- Olivotto I, Oreziak A, Barriales-Villa R, et al. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2020 Sep 12;396(10253):759–769. doi: 10.1016/S0140-6736(20)31792-X
- Ireland CG, Yu HY, McKenna WJ. Genetic testing in hypertrophic cardiomyopathy. Am J Cardiol. 2024 Feb 1;212S:S4–S13. doi: 10.1016/j.amjcard.2023.10.032
- Girolami F, Bardi S, Papi L, et al. Genetic testing and counselling in hypertrophic cardiomyopathy: Frequently asked questions. J Clin Med. 2023;12(7):2489. doi: 10.3390/jcm12072489
- Kaski JP, Norrish G. Family screening in gene-elusive hypertrophic cardiomyopathy: Time for a change or should we tread cautiously? J Am Coll Cardiol. 2023 Oct;82(12):1762–1764. doi: 10.1016/j.jacc.2023.09.003
- Wójcicka M, Łepek E, Siennicka A, Burzyńska B, Hoffman P, Szymański P. Psychological and clinical problems in young adults. Kardiol Pol. 2008 Oct;66(10):1050–1058; discussion 1059–60.
- Wheeler EC, Pretzer-Aboff I, Hardie T, DiSabatino A, Saylor J, Lucey R. Psychological impact of implantable cardioverter defibrillator on recipients. Dimens Crit Care Nurs. 2009 Jul–Aug;28(4):176–181. doi: 10.1097/DCC.0b013e3181a4743b